Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 1043-1052

  Napimoga, Marcelo H ^a   Da Silva, Carlos A T ^b   Carregaro, Vanessa ^c   Farnesi de Assunção, Thais S ^b   Duarte, Poliana M ^d   De Melo, Nathalie F S ^e,f   Fraceto, Leonardo F ^e,f  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^b FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d GUARULHOS UNIVERSITY   (Brazil)

^e UNIVERSITY OF CAMPINAS   (Brazil)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; NANOCAPSULE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; DOWN REGULATION; DRUG FORMULATION; IMMUNOMODULATION; IMMUNOREGULATION; INFRARED SPECTROSCOPY; MALE; MORPHOMETRICS; MOUSE; NANOTECHNOLOGY; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE RESORPTION; DISEASE MODELS, ANIMAL; GINGIVA; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; NANOCAPSULES; PERIODONTITIS; PROSTAGLANDIN D2;

EID: 84863613747     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200730     Document Type: Article

References (47)

1. Kajiya, M., G. Giro, M. A. Taubman, X. Han, M. P. Mayer, and T. Kawai. 2010. Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J. Oral Microbiol. DOI: 10.3402/jom.v2i0.5532.
2. Graves, D. T., D. Fine, Y. T. Teng, T. E. Van Dyke, and G. Hajishengallis. 2008. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 35: 89-105.
3. Tonetti, M. S., and A. Mombelli. 1999. Early-onset periodontitis. Ann. Periodontol. 4: 39-53.
4. Machion, L., D. C. Andia, G. Lecio, F. H. Nociti, Jr., M. Z. Casati, A. W. Sallum, and E. A. Sallum. 2006. Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: a 2-year follow-up. J. Periodontol. 77: 606-613. (Pubitemid 44725045)
5. Heitz-Mayfield, L. J. 2009. Systemic antibiotics in periodontal therapy. Aust. Dent. J. 54(Suppl. 1): S96-S101.
6. Hasturk, H., A. Kantarci, E. Goguet-Surmenian, A. Blackwood, C. Andry, C. N. Serhan, and T. E. Van Dyke. 2007. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 179: 7021-7029.
7. Trombone, A. P., S. B. Ferreira, Jr., F. M. Raimundo, K. C. de Moura, M. J. Avila-Campos, J. S. Silva, A. P. Campanelli, M. De Franco, and G. P. Garlet. 2009. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J. Periodontal Res. 44: 443-451.
8. Repeke, C. E., S. B. Ferreira, Jr., A. E. Vieira, E. M. Silveira, M. J. Avila- Campos, J. S. da Silva, C. F. Santos, A. P. Campanelli, A. P. Trombone, and G. P. Garlet. 2011. Dose-response met-RANTES treatment of experimental periodontitis: a narrow edge between the disease severity attenuation and infection control. PLoS One 6: e22526.
9. 2 metabolite generated during inflammatory processes. J. Biol. Chem. 277: 10459-10466.
10. Gilroy, D. W., T. Lawrence, M. Perretti, and A. G. Rossi. 2004. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3: 401-416. (Pubitemid 38618123)
11. 2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl. Acad. Sci. USA 104: 20979-20984.
12. Napimoga, M. H., S. M. Vieira, D. Dal-Secco, A. Freitas, F. O. Souto, F. L. Mestriner, J. C. Alves-Filho, R. Grespan, T. Kawai, S. H. Ferreira, and F. Q. Cunha. 2008. Peroxisome proliferator-activated receptor-γ ligand, 15-deoxy-D12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. J. Immunol. 180: 609-617.
13. Napimoga, M. H., G. R. Souza, T. M. Cunha, L. F. Ferrari, J. T. Clemente-Napimoga, C. A. Parada, W. A. Verri, Jr., F. Q. Cunha, and S. H. Ferreira. 2008. 15d-Prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. J. Pharmacol. Exp. Ther. 324: 313-321. (Pubitemid 350294144)
14. Díez-Dacal, B., and D. Pérez-Sala. 2010. Anti-inflammatory prostanoids: focus on the interactions between electrophile signaling and resolution of inflammation. ScientificWorldJournal 10: 655-675.
15. 2 in macrophages. Exp. Cell Res. 316: 3140-3149.
16. 2-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. Br. J. Pharmacol. 162: 623-632.
17. 2, reduce eosinophil recruitment following allergen challenge. Cell. Immunol. 273: 23-29.
18. 2 reduces lung inflammation and protects mice against lethal influenza infection. J. Infect. Dis. 205: 621-630.
19. Fessi, H., F. Puiseiux, J. P. Devissaguet, N. Ammoury, and S. Benita. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55: R1-R4. (Pubitemid 19247505)
20. Paavola, A., J. Yliruusi, Y. Kajimoto, E. Kalso, T. Wahlström, and P. Rosenberg. 1995. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm. Res. 12: 1997-2002. (Pubitemid 26032298)
21. Grillo, R., N. F. de Melo, D. R. de Araújo, E. de Paula, A. H. Rosa, and L. F. Fraceto. 2010. Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. J. Drug Target. 18: 688-699.
22. de Melo, N. F. S., R. Grillo, V. A. Guilherme, D. R. de Araujo, E. de Paula, A. H. Rosa, and L. F. Fraceto. 2011. Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. Pharm. Res. 28: 1984-1994.
23. Yu, J. J., M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, R. T. Evans, and S. L. Gaffen. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802. (Pubitemid 46641730)
24. Poletto, F. S., E. Jäger, M. I. Ré, S. S. Guterres, and A. R. Pohlmann. 2007. Ratemodulating PHBHV/PCL microparticles containing weak acid model drugs. Int. J. Pharm. 345: 70-80. (Pubitemid 350087543)
25. Hasturk, H., A. Kantarci, and T. E. Van Dyke. 2012. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 15: 160-176.
26. Surh, Y. J., H. K. Na, J. M. Park, H. N. Lee, W. Kim, I. S. Yoon, and D. D. Kim. 2011. 15-Deoxy-D12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. Biochem. Pharmacol. 82: 1335-1351.
27. Romero-Cano, M. S., and B. Vincent. 2002. Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles. J. Control. Release 82: 127-135. (Pubitemid 34775054)
28. Fu, Y., and W. J. Kao. 2010. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin. Drug Deliv. 7: 429-444.
29. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176. (Pubitemid 28180851)
30. Hassumi, M. Y., V. J. Silva-Filho, J. C. Campos-Júnior, S. M. Vieira, F. Q. Cunha, P. M. Alves, J. B. Alves, T. Kawai, R. B. Gonçalves, and M. H. Napimoga. 2009. PPAR-g agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis. Int. Immunopharmacol. 9: 1150-1158.
31. Napimoga, M. H., B. B. Benatti, F. O. Lima, P. M. Alves, A. C. Campos, D. R. Pena-Dos-Santos, F. P. Severino, F. Q. Cunha, and F. S. Guimarães. 2009. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int. Immunopharmacol. 9: 216-222.
32. Rodrigues, W. F., M. F. Madeira, T. A. da Silva, J. T. Clemente-Napimoga, C. B. Miguel, V. J. Dias-da-Silva, O. Barbosa-Neto, A. H. Lopes, and M. H. Napimoga. 2012. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. Br. J. Pharmacol. 165: 2140-2151 .
33. Bekker, P. J., D. Holloway, A. Nakanishi, M. Arrighi, P. T. Leese, and C. R. Dunstan. 2001. The effect of a single dose of osteoprotegerin in post-menopausal women. J. Bone Miner. Res. 16: 348-360. (Pubitemid 32105416)
34. Body, J. J., P. Greipp, R. E. Coleman, T. Facon, F. Geurs, J. P. Fermand, J. L. Harousseau, A. Lipton, X. Mariette, C. D. Williams, et al. 2003. A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer 97 (Suppl. 3): 887-892. (Pubitemid 36125828)
35. McClung, M. R., E. M. Lewiecki, S. B. Cohen, M. A. Bolognese, G. C. Woodson, A. H. Moffett, M. Peacock, P. D. Miller, S. N. Lederman, C. H. Chesnut, et al. 2006. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354: 821-831. (Pubitemid 43290920)
36. Body, J. J., T. Facon, R. E. Coleman, A. Lipton, F. Geurs, M. Fan, D. Holloway, M. C. Peterson, and P. J. Bekker. 2006. A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Clin. Cancer Res. 12: 1221-1228. (Pubitemid 43342512)
37. Lee, S. K., and J. Lorenzo. 2006. Cytokines regulating osteoclast formation and function. Curr. Opin. Rheumatol. 18: 411-418. (Pubitemid 44297288)
38. Smith, C. W. 1993. Endothelial adhesion molecules and their role in inflammation. Can. J. Physiol. Pharmacol. 71: 76-87. (Pubitemid 23172128)
39. 2 integrins: moderators of life or death decisions. Trends Immunol. 26: 388-395.
40. Shafren, D. R., D. J. Dorahy, R. F. Thorne, and R. D. Barry. 2000. Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. J. Gen. Virol. 81: 889-894. (Pubitemid 30189626)
41. Campbell, E. L., N. A. Louis, S. E. Tomassetti, G. O. Canny, M. Arita, C. N. Serhan, and S. P. Colgan. 2007. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21: 3162-3170. (Pubitemid 47565535)
42. Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N. Y. Karimbux, R. B. Goncalves, P. Valverde, S. Dibart, Y. P. Li, et al. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169: 987-998. (Pubitemid 44411961)
43. Nakajima, T., K. Ueki-Maruyama, T. Oda, Y. Ohsawa, H. Ito, G. J. Seymour, and K. Yamazaki. 2005. Regulatory T-cells infiltrate periodontal disease tissues. J. Dent. Res. 84: 639-643. (Pubitemid 43827846)
44. + natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J. Leukoc. Biol. 84: 311-318.
45. Dutzan, N., J. Gamonal, A. Silva, M. Sanz, and R. Vernal. 2009. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kB ligand, interleukin (IL)-17, IL-10 and transforming growth factor-βduring the progression of chronic periodontitis. J. Clin. Periodontol. 36: 396-403.
46. Garlet, G. P., C. R. Cardoso, F. S. Mariano, M. Claudino, G. F. de Assis, A. P. Campanelli, M. J. Ávila-Campos, and J. S. Silva. 2010. Regulatory T cells attenuate experimental periodontitis progression in mice. J. Clin. Periodontol. 37: 591-600.
47. Bell-Parikh, L. C., T. Ide, J. A. Lawson, P. McNamara, M. Reilly, and G. A. FitzGerald. 2003. Biosynthesis of 15-deoxy-D12,14-PGJ2 and the ligation of PPARg. J. Clin. Invest. 112: 945-955.